Genetic variability in ABCB1, occupational pesticide exposure, and Parkinson's disease

Environmental Research

Volumn 143, Issue , 2015, Pages 98-106

  Narayan, Shilpa ^a   Sinsheimer, Janet S ^b   Paul, Kimberly C ^a   Liew, Zeyan ^a   Cockburn, Myles ^c   Bronstein, Jeff M ^b   Ritz, Beate ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Epidemiology; Multidrug resistance protein 1 gene (ABCB1); P glycoprotein; Parkinson's disease; Pesticide

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN 1; ORGANOCHLORINE DERIVATIVE; PESTICIDE; ABCB1 PROTEIN, HUMAN; MULTIDRUG RESISTANCE PROTEIN;

CARDIOVASCULAR DISEASE; DISEASE TRANSMISSION; EPIDEMIOLOGY; GENE EXPRESSION; GENETIC VARIATION; GIS; HEALTH RISK; LAND USE; OCCUPATIONAL EXPOSURE; PESTICIDE APPLICATION; POLYMORPHISM; PROTEIN; XENOBIOTICS;

ADULT; ANCESTRY GROUP; ARTICLE; CONTROLLED STUDY; DATA BASE; FEMALE; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC INFORMATION SYSTEM; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; LAND USE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PARKINSON DISEASE; PRIORITY JOURNAL; SELF CONCEPT; SINGLE NUCLEOTIDE POLYMORPHISM; ADVERSE EFFECTS; AGED; ANALYSIS; CALIFORNIA; CASE CONTROL STUDY; GENETIC VARIATION; GENETICS; MIDDLE AGED; STATISTICAL ANALYSIS; VERY ELDERLY;

CALIFORNIA; EUROPE; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CALIFORNIA; CASE-CONTROL STUDIES; DATA INTERPRETATION, STATISTICAL; FEMALE; GENETIC VARIATION; GEOGRAPHIC INFORMATION SYSTEMS; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; P-GLYCOPROTEINS; PARKINSON DISEASE; PESTICIDES;

EID: 84944809863     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2015.08.022     Document Type: Article

References (55)

1. Bain L.J., et al. Structure-activity relationships for xenobiotic transport substrates and inhibitory ligands of P-glycoprotein. Environ. Health Perspect. 1997, 105:812-818.
2. Bendayan R., et al. In situ localization of P-glycoprotein (ABCB1) in human and rat brain. J. Histochem. Cytochem. 2006, 54:1159-1167.
3. Brown T.P., et al. Pesticides and Parkinson disease - is there a link?. Environ. Health Perspect. 2006, 114:156-164.
4. California Department of Pesticide Regulation, 2012. Product/Label Database. Available from: 〈〉 (accessed 12.12.12). http://www.cdpr.ca.gov/docs/label/prodnam.htm.
5. Cascorbi I., et al. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin. Pharmacol. Ther. 2001, 69:169-174.
6. Cordon-Cardo C., et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Natl. Acad. Sci. USA 1989, 86:695-698.
7. Corrigan F.M., et al. Organochlorine insecticides in substantia nigra in Parkinson disease. J. Toxicol. Environ. Health A 2000, 59:229-234.
8. Costello S., et al. Parkinson disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California. Am. J. Epidemiol. 2009, 169:919-926.
9. Droździk M., et al. Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson disease. Pharmacogenetics 2003, 13:259-263.
10. Dutheil F., et al. Interaction between ABCB1 and professional exposure to organochlorine insecticides in Parkinson disease. Arch. Neurol. 2010, 67:739-745.
11. Escuder-Gilabert L., et al. Permeability and toxicological profile estimation of organochlorine compounds by biopartitioning micellar chromatography. Biomed. Chromatogr. 2009, 23:382-389.
12. Fitzmaurice A.G., et al. Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson disease. Neurology 2014, 82:419-426.
13. Fleming L., et al. Parkinson disease and brain levels of organochlorine pesticides. Ann. Neurol. 1994, 36:100-103.
14. Funke C., et al. Genetic analysis of coding SNPs in blood-brain barrier transporter MDR1 in European Parkinson disease patients. J. Neural Transm. 2009, 116:443-450.
15. Furuno T., et al. Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson disease. Pharmacogenetics 2002, 12:529-534.
16. Gatto N.M., et al. Well-water consumption and Parkinson disease in rural California. Environ. Health Perspect. 2009, 117:1912-1918.
17. Gauderman, W., Morrison, J., 2006. QUANTO 1.1: A Computer Program for Power and Sample Size Calculations for Genetic-Epidemiology Studies. 〈. http://hydra.usc.edu/gxe.
18. Goldberg D.W., et al. An effective and efficient approach for manually improving geocoded data. Int. J. Health Geogr. 2008, 7:60.
19. Graff C.L., Pollack G.M. Functional evidence for P-glycoprotein at the nose-brain barrier. Pharm. Res. 2005, 22:86-93.
20. Hamajima N., et al. Detection of gene-environment interaction by case-only studies. Jpn. J. Clin. Oncol. 1999, 29:490-493.
21. Hitzl M., et al. Variable expression of P-glycoprotein in the human placenta and its association with mutations of the multidrug resistance 1 gene (MDR1, ABCB1). Pharmacogenetics 2004, 14:309-318.
22. Hughes A.J., et al. What features improve the accuracy of clinical diagnosis in Parkinson disease: a clinicopathologic study. Neurology 1992, 42:1142-1146.
23. Ioannidis J.P. Why most discovered true associations are inflated. Epidemiology 2008, 19:640-648.
24. Kang G.A., et al. Clinical characteristics in early Parkinson disease in a central California population-based study. Mov. Disord. 2005, 20:1133-1142.
25. Kimchi-Sarfaty C., et al. A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 2007, 315:525-528.
26. Kiyohara C., et al. MDR1 C3435T polymorphism and interaction with environmental factors in risk of Parkinson disease: a case-control study in Japan. Drug Metab. Pharmacokinet. 2013, 28:138-143.
27. Lecoeur S., et al. Effect of organophosphate pesticide diazinon on expression and activity of intestinal P-glycoprotein. Toxicol. Lett. 2006, 161:200-209.
28. Lee C.G., et al. MDR1, the blood-brain barrier transporter, is associated with Parkinson disease in ethnic Chinese. J. Med. Genet. 2004, 41:e60.
29. Lee P.C., et al. Functional paraoxonase 1 variants modify the risk of Parkinson disease due to organophosphate exposure. Environ. Int. 2013, 56:42-47.
30. Liew Z., et al. Job exposure matrix (JEM)-derived estimates of lifetime occupational pesticide exposure and the risk of Parkinson disease. Arch. Environ. Occup. Health 2014, 69:241-251.
31. Mahringer A., et al. The ABC of the blood-brain barrier - regulation of drug efflux pumps. Curr. Pharm. Des. 2011, 17:2762-2770.
32. Marzolini C., et al. Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin. Pharmacol. Ther. 2004, 75:13-33.
33. Mizuta I., et al. Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson disease. Hum. Mol. Genet. 2006, 15:1151-1158.
34. Mizuta I., et al. Calbindin 1, fibroblast growth factor 20, and alpha-synuclein in sporadic Parkinson disease. Hum. Genet. 2008, 124:89-94.
35. Nalls M.A., et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson disease. Nat. Genet. 2014, 46:989-993.
36. Narayan S., et al. Household organophosphorus pesticide use and Parkinson disease. Int. J. Epidemiol. 2013, 42:1476-1485.
37. Newkirk L.A., et al. Validation of a 26-point telephone version of the Mini-Mental State Examination. J Geriatr. Psychiatry Neurol. 2004, 17:81-87.
38. Parran D.K., et al. Chlorpyrifos alters functional integrity and structure of an in vitro BBB model: co-cultures of bovine endothelial cells and neonatal rat astrocytes. Neurotoxicology 2005, 26:77-88.
39. Pesticide Action Network, 2012. PAN Pesticide Database - Chemicals. Available from: 〈〉 (accessed: 12.12.12). http://www.pesticideinfo.org/Search_Chemicals.jsp.
40. Rhodes S.L., et al. Pesticides that inhibit the ubiquitin-proteasome system: effect measure modification by genetic variation in SKP1 in Parkinsons disease. Environ. Res. 2013, 126:1-8.
41. Rull R.P., Ritz B. Historical pesticide exposure in California using pesticide use reports and land-use surveys: an assessment of misclassification error and bias. Environ. Health Perspect. 2003, 111:1582-1589.
42. Salama N.N., et al. MDR1 haplotypes significantly minimize intracellular uptake and transcellular P-gp substrate transport in recombinant LLC-PK1 cells. J. Pharm. Sci. 2006, 95:2293-2308.
43. Schinkel A.H., et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994, 77:491-502.
44. Sreeramulu K., et al. Interaction of insecticides with mammalian P-glycoprotein and their effect on its transport function. Biochim. Biophys. Acta 2007, 1768:1750-1757.
45. Sugihara N., et al. Effects of benzo(e)pyrene and benzo(a)pyrene on P-glycoprotein-mediated transport in Caco-2 cell monolayer: a comparative approach. Toxicol. in Vitro 2007, 21:827-834.
46. Tan E.K., et al. Effect of MDR1 haplotype on risk of Parkinson disease. Arch. Neurol. 2005, 62:460-464.
47. Tan E.K., et al. Analysis of MDR1 haplotypes in Parkinson's disease in a white population. Neurosci. Lett. 2004, 372:240-244.
48. Toda T., et al. Toward identification of susceptibility genes for sporadic Parkinson's disease. J. Neurol. 2003, 250(Suppl. 3):III40-III43.
49. van der Mark M., et al. Is pesticide use related to Parkinson disease? Some clues to heterogeneity in study results. Environ. Health Perspect. 2012, 120:340-347.
50. Wang A., et al. The association between ambient exposure to organophosphates and Parkinson disease risk. Occup. Environ. Med. 2014, 71:275-281.
51. Wang A., et al. Parkinson disease risk from ambient exposure to pesticides. Eur. J. Epidemiol. 2011, 26:547-555.
52. Wang D., et al. Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability. Pharmacogenet. Genomics. 2005, 15:693-704.
53. Westerlund M., et al. Association of a polymorphism in the ABCB1 gene with Parkinson disease. Parkinsonism. Relat. Disord. 2009, 15:422-424.
54. Wood, A. 2012. Compendium of Pesticide Common Names. Available from: 〈 (accessed 12.12.12). http://www.alanwood.net/pesticides/.
55. Zschiedrich K., et al. MDR1 variants and risk of Parkinson disease. Association with pesticide exposure?. J. Neurol. 2009, 256:115-120.